Paul Hastings, Sidley Austin, and Maples Group have advised Accelerant. Houlihan Lokey and Conyers Dill & Pearman have advised the Special Committee of Accelerant. Goodwin Procter,...
Accelerant Enters Into $4 Billion Take-Private Acquisition by Thoma Bravo
TA Associates Announces Strategic Growth Investment in Oxane Partners
Trilegal has advised Oxane Partners and its shareholders. Goodwin Procter LLP has advised TA Associates. Oxane Partners and its shareholders have entered into an agreement for...
Forterro Acquires 3E Schweiz AG to Enhance European Industrial Software Offering
MLL Legal and Goodwin Procter have advised Forterro on its acquisition of 3E Schweiz AG. Forterro, a prominent European provider of industrial software solutions, has announced...
Miro’s Acquisition of Freehand
Goodwin advised Miro in its acquisition of Freehand. Miro has acquired the visual collaboration platform, Freehand, from InVision. The deal includes the technology and brand assets, customer...
H.I.G. Capital’s Acquisition of CLC Group Limited
Goodwin advised H.I.G. Capital on the deal. H.I.G. Capital, LLC announced that one of its affiliates acquired CLC Group Limited from its owner, the Armitage Family...
Closed Loop Medicine’s Global Co-Development Partnership with Pharmanovia
Goodwin advised Closed Loop Medicine on the deal. Closed Loop Medicine Ltd and Pharmanovia announced that they have entered a global co-development partnership. The partnership will initially...
Imprivata’s Acquisition of OGiTiX Software AG
Goodwin advised Imprivata Inc. on the deal. CMS advised the majority shareholders of Ogitix Software. Imprivata, the digital identity company for mission- and life-critical industries, announced...
TowerBrook Capital Partners’ Acquisition of Premium Credit from Cinven
Freshfields Bruckhaus Deringer advised international private equity firm Cinven on the deal. Travers Smith LLP advised the management team of Premium Credit. Goodwin represented TowerBrook Capital...
Centauri Therapeutics’ $32 Million Series A Investment
Goodwin advised BIVF, Novo and Evotec on the deal. Boehringer Ingelheim Venture Fund GmbH (“BIVF”), Novo Holdings REPAIR Impact Fund (“Novo”) and Evotec SE (“Evotec”) led...
ieso’s $53 Million Series B Funding Round
Goodwin Procter advised Morningside on the deal. Morningside announced its lead investment into ieso, as part of a $53m Series B funding round which included investments from...